US Patent

US11723858 — Topical antiviral compositions, delivery systems, and methods of using the same

Method of Use · Assigned to Novan Inc · Expires 2035-07-10 · 9y remaining

Vulnerability score 75/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects topical antiviral compositions, delivery systems, and methods of using them, assigned to Novan Inc.

USPTO Abstract

The present invention relates generally to topical antiviral compositions, delivery systems, and methods of using the same.

Drugs covered by this patent

berdazimer-sodium (BERDAZIMER SODIUM)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3788`	—	berdazimer-sodium

Patent Metadata

Patent number: US11723858
Jurisdiction: US
Classification: Method of Use
Expires: 2035-07-10
Drug substance claim: No
Drug product claim: Yes
Assignee: Novan Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.